Financials

  • Market Capitalization 7.95 M
  • Employee 6
  • Founded 2016
  • CEO N/A
  • Website www.alzamend.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZMXG7M8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.43
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4814
SNGX
Soligenix, Inc. - Common Stock
0.38 USD0.00%-7.32%+2.70%-66.37%8.27 M USD
4817
CNSP
CNS Pharmaceuticals, Inc. - Common Stock
5.52 USD0.00%-3.16%+13.81%-10.97%8.07 M USD
4824
AIM
AIM ImmunoTech Inc. Common Stock
0.26 USD+4.00%0.00%+8.33%-89.65%7.91 M USD
4826
SKYE
Skye Bioscience, Inc. - Common Stock
1.78 USD-8.72%-21.24%+191.80%+122.50%7.88 M USD

Notizie